Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

Novartis Investigative Site, Basel

Weill Cornell Medical Center, New York

Novartis Investigative Site, Bangkok

Fox Chase Cancer Center, Philadelphia

Sidney Kimmel CCC At JH, Baltimore

Novartis Investigative Site, Pessac

Karmanos Cancer Institute, Detroit

Novartis Investigative Site, Lille

Northwestern University, Chicago

Uni Of TX MD Anderson Cancer Cntr, Houston

Novartis Investigative Site, Poitiers

University of California LA, Los Angeles

Oregon Health Sciences University, Portland

Novartis Investigative Site, Beijing

Novartis Investigative Site, Beijing

Novartis Investigative Site, Singapore

Novartis Investigative Site, Singapore

Novartis Investigative Site, Singapore

Novartis Investigative Site, Shanghai

Novartis Investigative Site, Nanjing

Novartis Investigative Site, Cluj-Napoca

Novartis Investigative Site, Guangzhou

Novartis Investigative Site, Pokfulam

Dana Farber Cancer Institute, Boston

Novartis Investigative Site, Helsinki

Novartis Investigative Site, Bucharest

Novartis Investigative Site, Ankara

Novartis Investigative Site, Sutton

Novartis Investigative Site, Manchester